Article ID Journal Published Year Pages File Type
8236894 International Journal of Radiation Oncology*Biology*Physics 2008 8 Pages PDF
Abstract
The HDR brachytherapy of a single implant with two fractions plus EBRT is effective in treating patients with localized hormone-naive prostate cancer, with the least genitourinary and gastrointestinal toxicities; however, longer median BF-FCR follow-up is required to assess these findings.
Related Topics
Physical Sciences and Engineering Physics and Astronomy Radiation
Authors
, , , , , ,